8 Results for "

LPAR1 antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "LPAR1 antagonist" in MCE Product Catalog:

Cat. No.: HY-162267
CAS No.: 3032275-33-2
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

LPAR1 antagonist 1 (compound 18) is a potent, oral active and selective LPAR1 antagonist with the IC50 of 3.3 nM. LPAR1 antagonist 1 can be used for study of fibrosis .
loading...
    loading...
Cat. No.: HY-159983
CAS No.: 2750508-72-4
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

GS-2278 is an LPAR1 (lysophosphatidic acid receptor 1) antagonist with potential for research in idiopathic pulmonary fibrosis (IPF) .
loading...
    loading...
Cat. No.: HY-160661
CAS No.: 1664336-46-2
Target:  

LPL Receptor

Research Areas:  

Others

LPAR1 antagonist 2 (example 76) is an LPAR1 antagonist with an average IC50 of 130 nM .
loading...
    loading...
Cat. No.: HY-65255
CAS No.: 5521-58-4
2-Amino-5-methylpyrazine is an intermediate. 2-Amino-5-methylpyrazine can be used to synthesize LPAR1 antagonists .
loading...
    loading...
Cat. No.: HY-171806
CAS No.: 1257213-96-9
Target:  

LPL Receptor

Research Areas:  

Cancer

BMT-136088 is a LPAR1 antagonist . 11C-BMT-136088 can be used as a positron emission tomography (PET) radioligand to quantify specific binding to LPA1 in lung.
loading...
    loading...
Cat. No.: HY-120282
CAS No.: 1802079-45-3
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

ONO-9910539 is a lysophosphatidic acid receptor 1 (LPAR1) antagonist. ONO-9910539 is applicable to the research of idiopathic pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-184986
CAS No.: 2901868-37-7
PIPE-791 is an orally active, blood-brain barrier-permeable selective antagonist of LPAR1. PIPE-791 inhibits LPA-induced calcium mobilization, collagen expression, histamine release, and the activation of fibroblasts, microglia and macrophages. PIPE-791 induces oligodendrocyte precursor cell differentiation, myelination and remyelination, and increases the number of microglia in the retina of normotensive rats. PIPE-791 protects mature oligodendrocytes from cytokine-induced death, reduces the levels of pulmonary fibrosis markers and alleviates neuroinflammation in preclinical models. PIPE-791 can be used in the research of glaucoma, neuroinflammatory diseases, chronic osteoarthritis pain, idiopathic pulmonary fibrosis and multiple sclerosis .
loading...
    loading...
Cat. No.: HY-182787
CAS No.: 3057457-78-7
Target:  

LPL Receptor

Research Areas:  

Cancer

LPA1 receptor antagonist-7 is a LPA1 antagonist. LPA1 receptor antagonist-7 blocks downstream signaling pathways mediated by LPA1. LPA1 receptor antagonist-7 inhibits LPA-induced migration and invasion of cancer cells. LPA1 receptor antagonist-7 can be used for the research of triple-negative breast cancer .
loading...
    loading...